NCT00959517View on ClinicalTrials.gov

Trial of Artesunate Combination Therapy in Pakistan

PHASE2CompletedINTERVENTIONAL

Enrollment

588

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

June 30, 2005

Study Completion Date

August 31, 2006

Conditions

Uncomplicated Falciparum Malaria

Interventions

DRUG

artesunate (AS)

Recommended dosage over 3 days (for all interventions)

DRUG

sulphadoxine-pyrimethamine (SP)

DRUG

Chloroquine (CQ)

DRUG

primaquine (PQ)

Trial Locations (1)

Unknown

HealthNet International, Peshawar

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

HealthNet TPO

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER